Delivery Order SPE2DB20D1109-SPE2DB25FP56L
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,341.04 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count units). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitively awarded, non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order operates under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to...
- The Defense Logistics Agency awarded a delivery order valued at $5,717.72 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,124.66 by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 4, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $7,571.76 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Topiramate ER 200 mg capsules. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,580.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 50 mg tablets (1,000 count) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,195.98 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,003.47. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP56LDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing $999.999 billion IDC with DLA Troop Support Medical (SPE2DX contract), running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/12/25 |